IHS Chemical Week

World News and Views :: Projects

NPIL Pharma to Expand Capacity

October 17, 2007 | DR

NPIL Pharma, the custom manufacturing division of Nicholas Piramal India Ltd. (NPIL; Mumbai), says it will invest about $4 million in its early phase pharma development and scale-up (PDS) facility at Chennai, southern India. NPIL is India’s fourth-largest pharmaceutical company. NPIL says it will add eight new reactors with 12,000 liters of capacity to its Chennai cGMP plant by year-end. New facilities will be installed for manufacturing final active pharmaceutical ingredients (API), with a clean room for final API powder processing and packing. A new...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa